Table of Contents Table of Contents
Previous Page  52 / 88 Next Page
Information
Show Menu
Previous Page 52 / 88 Next Page
Page Background

52

Scientific Programme /

Wednesday, 21 June 2017

WFSBP 2017

WED

T20: LIAISON PSYCHIATRY

TFS-07

WFSBP TASK FORCE SYMPOSIUM

11:15–12:45

Congress Hall A 3

Enhancing the role of primary care in looking after

people with mental health problems: A new position

paper from the Collaborative Care Task Force of the

WFSBP

Chair:

Nick Kates, Canada

001

Improving primary mental health care –

Definitions, models, principles and challenges

Nick Kates, Canada

002

Integrating mental health services within primary

care settings

Henrikje Klasen, The Netherlands

003

The role of the family physician in delivering

mental health care

Torleif Ruud, Norway

004

Capacity building, training and adapting the

approach for different countries

Nick Kates, Canada

T32: PHARMACOGENETICS

S-48

SYMPOSIUM

11:15–12:45

Auditorium 12

Pharmacogenetics of drug defense and neuro-

protection: From the Neandertal to the modern

humans

Chair:

Julia Stingl, Germany

Co-Chair: Magnus Ingelman-Sundberg, Sweden

001

The evolutionary aspect of trait biomarkers in drug

metabolism and neuroprotection

Magnus Ingelman-Sundberg, Sweden

002

Pharmacogenetic polymorphisms on behavioral

and structural brain phenotypes uncovered by neuro-

imaging data

Roberto Viviani, Germany

003

Prevention of drug toxicity to the brain: The vul-

nerable brain and ADRs of nervous system disorders

Julia Stingl, Germany

004

Serotonin Transporter Expression Variability: Role

in Neurogenesis and Pharmacological Modulation

Abdul-Karim Barakat, Germany

T11: DEPRESSION: BASIC/ CLINICAL

S-49

SYMPOSIUM

11:15–12:45

Auditorium 10

Evidence-based guidelines for treatment of major

depressive disorder: Contrasting views across the

world

Chair:

Roumen Milev, Canada

Co-Chair: Allan Young, United Kingdom

001

Evolution of WFSBP depression guidelines

Michael Bauer, Germany

002

The evolution of the CANMAT guidelines

Raymond Lam, Canada

003

The view from the UK: BAP guidelines for Mood

Disorders (MD)

Allan Young, United Kingdom

004

Even the best guidelines don't work unless they are

implemented

Sagar Parikh, USA

T6: BIPOLAR DISORDERS: BASIC/ CLINICAL

S-50

SYMPOSIUM

11:15–12:45

Auditorium 11

Real time assessment of psychopathology and behavior

in Bipolar Disorder (BP) using e-mental health

technologies

Chair:

Lars Kessing, Denmark

Co-Chair: Michael Bauer, Germany

001

Mood instability and Bipolar Disorder (BD):

Deriving useful biosignatures from multidimensional,

time stamped, streamed data

John Geddes, United Kingdom

002

Smartphones as objective electronic behavioral

biomarkers of illness activity in Bipolar Disorder (BP)

Lars Kessing, Denmark

003

Voice recognition as objective electronic behavior-

al biomarkers of illness activity in Bipolar Disorder (BP)

Maria Fauerholt-Jepsen, Denmark

004

Smartphone based ambulatory assessment of early

warning signs in Bipolar Disorder (BP)

Michael Bauer, Germany